Global Cell Line Development Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
The Global Cell Line Development Market is expected to grow from USD 3,164.48 Million in 2018 to USD 6,358.96 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 10.48%.
The positioning of the Global Cell Line Development Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell Line Development Market including are American Type Culture Collection, Corning, Inc., European Collection of Cell Cultures, GE Healthcare, Lonza Group AG, Aragen Bioscience, Eubiologics CO., LTD., Gallus Biopharmaceuticals, Paragon Bioservices, Inc., Public Health England, Samsung Biologics, Sartorius AG, Selexis SA, Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Vista Biologicals Corporation, and Wuxi Apptec.
On the basis of Type, the Global Cell Line Development Market is studied across Continuous Cell Lines, Hybridomas, Primary Cell Lines, and Recombinant Cell Lines.
On the basis of Sera, the Global Cell Line Development Market is studied across Adult Bovine Sera and Fetal Bovine Sera.
On the basis of Reagents, the Global Cell Line Development Market is studied across Buffers & Chemicals, Cell Dissociation Reagents, Cryopreservative Reagents, and Supplements & Growth Factors.
On the basis of Media, the Global Cell Line Development Market is studied across Minimum Essential Media, Reduced Serum Media, and Serum-Free Media.
On the basis of Source, the Global Cell Line Development Market is studied across Amphibian, Insect, and Mammalian.
On the basis of Equipment, the Global Cell Line Development Market is studied across Automation Systems, Bioreactors, Biosafety Cabinets, Cell Counters & Viability Analysis Systems, Centrifuges, Filtration Systems, Incubators, Microscopes, and Storage Equipment.
On the basis of Application, the Global Cell Line Development Market is studied across Bioproduction, Drug Discovery, Research, Tissue Engineering & Regenerative Medicine, and Toxicity Testing.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Cell Line Development Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Cell Line Development Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Cell Line Development Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Cell Line Development Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Cell Line Development Market
The report answers questions such as:
1. What is the market size of Cell Line Development market in the Global?
2. What are the factors that affect the growth in the Global Cell Line Development Market over the forecast period?
3. What is the competitive position in the Global Cell Line Development Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Cell Line Development Market?
5. What are the opportunities in the Global Cell Line Development Market?
6. What are the modes of entering the Global Cell Line Development Market?
The positioning of the Global Cell Line Development Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell Line Development Market including are American Type Culture Collection, Corning, Inc., European Collection of Cell Cultures, GE Healthcare, Lonza Group AG, Aragen Bioscience, Eubiologics CO., LTD., Gallus Biopharmaceuticals, Paragon Bioservices, Inc., Public Health England, Samsung Biologics, Sartorius AG, Selexis SA, Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Vista Biologicals Corporation, and Wuxi Apptec.
On the basis of Type, the Global Cell Line Development Market is studied across Continuous Cell Lines, Hybridomas, Primary Cell Lines, and Recombinant Cell Lines.
On the basis of Sera, the Global Cell Line Development Market is studied across Adult Bovine Sera and Fetal Bovine Sera.
On the basis of Reagents, the Global Cell Line Development Market is studied across Buffers & Chemicals, Cell Dissociation Reagents, Cryopreservative Reagents, and Supplements & Growth Factors.
On the basis of Media, the Global Cell Line Development Market is studied across Minimum Essential Media, Reduced Serum Media, and Serum-Free Media.
On the basis of Source, the Global Cell Line Development Market is studied across Amphibian, Insect, and Mammalian.
On the basis of Equipment, the Global Cell Line Development Market is studied across Automation Systems, Bioreactors, Biosafety Cabinets, Cell Counters & Viability Analysis Systems, Centrifuges, Filtration Systems, Incubators, Microscopes, and Storage Equipment.
On the basis of Application, the Global Cell Line Development Market is studied across Bioproduction, Drug Discovery, Research, Tissue Engineering & Regenerative Medicine, and Toxicity Testing.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Cell Line Development Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Cell Line Development Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Cell Line Development Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Cell Line Development Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Cell Line Development Market
The report answers questions such as:
1. What is the market size of Cell Line Development market in the Global?
2. What are the factors that affect the growth in the Global Cell Line Development Market over the forecast period?
3. What is the competitive position in the Global Cell Line Development Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Cell Line Development Market?
5. What are the opportunities in the Global Cell Line Development Market?
6. What are the modes of entering the Global Cell Line Development Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Cell Line Development Market
3.2. Opportunities in the Cell Line Development Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increase demand for monoclonal antibodies owing to increase application
4.2.1.2. Innovative technologies coupled with increased participation of research institutes and government agency
4.2.1.3. Growing rise in vaccine production
4.2.2. Restraints
4.2.2.1. Limited awareness and high cost associated with the product and applications
4.2.3. Opportunities
4.2.3.1. Increasing risk of communicable pandemics diseases
4.2.3.2. Potential in low-income countries
4.2.4. Challenges
4.2.4.1. Developing authentic and stable cell lines
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
4.4.1. Technology Advancement
4.4.1.1. Methotrexate Amplification Technology
4.4.1.2. Glutamine Synthatase Technology
4.4.1.3. Viral-Based Technology
5. GLOBAL CELL LINE DEVELOPMENT MARKET, BY TYPE
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Continuous Cell Lines
5.4. Hybridomas
5.5. Primary Cell Lines
5.6. Recombinant Cell Lines
6. GLOBAL CELL LINE DEVELOPMENT MARKET, BY SERA
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Adult Bovine Sera
6.4. Fetal Bovine Sera
7. GLOBAL CELL LINE DEVELOPMENT MARKET, BY REAGENTS
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Buffers & Chemicals
7.4. Cell Dissociation Reagents
7.5. Cryopreservative Reagents
7.6. Supplements & Growth Factors
8. GLOBAL CELL LINE DEVELOPMENT MARKET, BY MEDIA
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Minimum Essential Media
8.4. Reduced Serum Media
8.5. Serum-Free Media
9. GLOBAL CELL LINE DEVELOPMENT MARKET, BY SOURCE
9.1. Overview
9.2. Market Sizing & Forecasting
9.3. Amphibian
9.4. Insect
9.5. Mammalian
10. GLOBAL CELL LINE DEVELOPMENT MARKET, BY EQUIPMENT
10.1. Overview
10.2. Market Sizing & Forecasting
10.3. Automation Systems
10.4. Bioreactors
10.5. Biosafety Cabinets
10.6. Cell Counters & Viability Analysis Systems
10.7. Centrifuges
10.8. Filtration Systems
10.9. Incubators
10.10. Microscopes
10.11. Storage Equipment
10.11.1. Cryostorage Systems
10.11.2. Refrigerators & Freezers
11. GLOBAL CELL LINE DEVELOPMENT MARKET, BY APPLICATION
11.1. Overview
11.2. Market Sizing & Forecasting
11.3. Bioproduction
11.3.1. Diagnostics
11.3.2. Recombinant Protein Therapeutics
11.3.3. Vaccine Production
11.4. Drug Discovery
11.4.1. Disease Modeling
11.4.2. Drug Screening and Development
11.4.3. Target Validation
11.5. Research
11.6. Tissue Engineering & Regenerative Medicine
11.7. Toxicity Testing
12. GLOBAL CELL LINE DEVELOPMENT MARKET, BY GEOGRAPHY
12.1. Overview
12.2. Market Sizing & Forecasting
12.3. Americas
12.3.1. Overview
12.3.2. Market Sizing & Forecasting
12.3.3. Argentina
12.3.4. Brazil
12.3.5. Canada
12.3.6. Mexico
12.3.7. United States
12.4. Asia-Pacific
12.4.1. Overview
12.4.2. Market Sizing & Forecasting
12.4.3. Australia
12.4.4. China
12.4.5. India
12.4.6. Japan
12.5. Europe, Middle East & Africa
12.5.1. Overview
12.5.2. Market Sizing & Forecasting
12.5.3. France
12.5.4. Germany
12.5.5. Italy
12.5.6. Spain
12.5.7. United Kingdom
13. COMPETITIVE LANDSCAPE
13.1. 360iResearch FPNV Positioning Matrix for Global Cell Line Development Market
13.2. Market Vendor Ranking Analysis for Global Cell Line Development Market
13.3. Competitive News Feed Analysis for Global Cell Line Development Market
14. COMPANY USABILITY PROFILES
14.1. American Type Culture Collection
14.1.1. Overview
14.1.2. Strategy
14.1.3. SWOT
14.2. Corning, Inc.
14.2.1. Overview
14.2.2. Strategy
14.2.3. SWOT
14.3. European Collection of Cell Cultures
14.3.1. Overview
14.3.2. Strategy
14.3.3. SWOT
14.4. GE Healthcare
14.4.1. Overview
14.4.2. Strategy
14.4.3. SWOT
14.5. Lonza Group AG
14.5.1. Overview
14.5.2. Strategy
14.5.3. SWOT
14.6. Aragen Bioscience
14.7. Eubiologics CO., LTD.
14.8. Gallus Biopharmaceuticals
14.9. Paragon Bioservices, Inc.
14.10. Public Health England
14.11. Samsung Biologics
14.12. Sartorius AG
14.13. Selexis SA
14.14. Sigma-Aldrich Corporation
14.15. Thermo Fisher Scientific, Inc.
14.16. Vista Biologicals Corporation
14.17. Wuxi Apptec
15. APPENDIX
15.1. Discussion Guide
15.2. Top Reports
15.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
15.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
15.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
15.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
15.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
15.3. Author Details
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Cell Line Development Market
3.2. Opportunities in the Cell Line Development Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increase demand for monoclonal antibodies owing to increase application
4.2.1.2. Innovative technologies coupled with increased participation of research institutes and government agency
4.2.1.3. Growing rise in vaccine production
4.2.2. Restraints
4.2.2.1. Limited awareness and high cost associated with the product and applications
4.2.3. Opportunities
4.2.3.1. Increasing risk of communicable pandemics diseases
4.2.3.2. Potential in low-income countries
4.2.4. Challenges
4.2.4.1. Developing authentic and stable cell lines
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
4.4.1. Technology Advancement
4.4.1.1. Methotrexate Amplification Technology
4.4.1.2. Glutamine Synthatase Technology
4.4.1.3. Viral-Based Technology
5. GLOBAL CELL LINE DEVELOPMENT MARKET, BY TYPE
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Continuous Cell Lines
5.4. Hybridomas
5.5. Primary Cell Lines
5.6. Recombinant Cell Lines
6. GLOBAL CELL LINE DEVELOPMENT MARKET, BY SERA
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Adult Bovine Sera
6.4. Fetal Bovine Sera
7. GLOBAL CELL LINE DEVELOPMENT MARKET, BY REAGENTS
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Buffers & Chemicals
7.4. Cell Dissociation Reagents
7.5. Cryopreservative Reagents
7.6. Supplements & Growth Factors
8. GLOBAL CELL LINE DEVELOPMENT MARKET, BY MEDIA
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Minimum Essential Media
8.4. Reduced Serum Media
8.5. Serum-Free Media
9. GLOBAL CELL LINE DEVELOPMENT MARKET, BY SOURCE
9.1. Overview
9.2. Market Sizing & Forecasting
9.3. Amphibian
9.4. Insect
9.5. Mammalian
10. GLOBAL CELL LINE DEVELOPMENT MARKET, BY EQUIPMENT
10.1. Overview
10.2. Market Sizing & Forecasting
10.3. Automation Systems
10.4. Bioreactors
10.5. Biosafety Cabinets
10.6. Cell Counters & Viability Analysis Systems
10.7. Centrifuges
10.8. Filtration Systems
10.9. Incubators
10.10. Microscopes
10.11. Storage Equipment
10.11.1. Cryostorage Systems
10.11.2. Refrigerators & Freezers
11. GLOBAL CELL LINE DEVELOPMENT MARKET, BY APPLICATION
11.1. Overview
11.2. Market Sizing & Forecasting
11.3. Bioproduction
11.3.1. Diagnostics
11.3.2. Recombinant Protein Therapeutics
11.3.3. Vaccine Production
11.4. Drug Discovery
11.4.1. Disease Modeling
11.4.2. Drug Screening and Development
11.4.3. Target Validation
11.5. Research
11.6. Tissue Engineering & Regenerative Medicine
11.7. Toxicity Testing
12. GLOBAL CELL LINE DEVELOPMENT MARKET, BY GEOGRAPHY
12.1. Overview
12.2. Market Sizing & Forecasting
12.3. Americas
12.3.1. Overview
12.3.2. Market Sizing & Forecasting
12.3.3. Argentina
12.3.4. Brazil
12.3.5. Canada
12.3.6. Mexico
12.3.7. United States
12.4. Asia-Pacific
12.4.1. Overview
12.4.2. Market Sizing & Forecasting
12.4.3. Australia
12.4.4. China
12.4.5. India
12.4.6. Japan
12.5. Europe, Middle East & Africa
12.5.1. Overview
12.5.2. Market Sizing & Forecasting
12.5.3. France
12.5.4. Germany
12.5.5. Italy
12.5.6. Spain
12.5.7. United Kingdom
13. COMPETITIVE LANDSCAPE
13.1. 360iResearch FPNV Positioning Matrix for Global Cell Line Development Market
13.2. Market Vendor Ranking Analysis for Global Cell Line Development Market
13.3. Competitive News Feed Analysis for Global Cell Line Development Market
14. COMPANY USABILITY PROFILES
14.1. American Type Culture Collection
14.1.1. Overview
14.1.2. Strategy
14.1.3. SWOT
14.2. Corning, Inc.
14.2.1. Overview
14.2.2. Strategy
14.2.3. SWOT
14.3. European Collection of Cell Cultures
14.3.1. Overview
14.3.2. Strategy
14.3.3. SWOT
14.4. GE Healthcare
14.4.1. Overview
14.4.2. Strategy
14.4.3. SWOT
14.5. Lonza Group AG
14.5.1. Overview
14.5.2. Strategy
14.5.3. SWOT
14.6. Aragen Bioscience
14.7. Eubiologics CO., LTD.
14.8. Gallus Biopharmaceuticals
14.9. Paragon Bioservices, Inc.
14.10. Public Health England
14.11. Samsung Biologics
14.12. Sartorius AG
14.13. Selexis SA
14.14. Sigma-Aldrich Corporation
14.15. Thermo Fisher Scientific, Inc.
14.16. Vista Biologicals Corporation
14.17. Wuxi Apptec
15. APPENDIX
15.1. Discussion Guide
15.2. Top Reports
15.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
15.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
15.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
15.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
15.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
15.3. Author Details
